Patents by Inventor Anna Gill

Anna Gill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11857534
    Abstract: Methods are disclosed for treating neurodegenerative disorders, such as ALS and FTD by using an effective amount of a type I protein arginine methyltransferase (Type I PRMT) inhibitor to decrease cellular toxicity caused by dipeptide repeat proteins (DRPs).
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: January 2, 2024
    Assignee: ALS Therapy Development Institute
    Inventors: Fernando G. Vieira, Alan Premasiri, Anna Gill
  • Patent number: 11607402
    Abstract: Methods are disclosed for treating neurodegenerative disorders, such as ALS and FTD by using an effective amount of a type I protein arginine methyltransferase (Type I PRMT) inhibitor to decrease cellular toxicity caused by dipeptide repeat proteins (DRPs).
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: March 21, 2023
    Assignee: ALS Therapy Development Institute
    Inventors: Fernando G. Vieira, Alan Premasiri, Anna Gill
  • Publication number: 20220142974
    Abstract: Methods are disclosed for treating neurodegenerative disorders, such as ALS and FTD by using an effective amount of a type I protein arginine methyltransferase (Type I PRMT) inhibitor to decrease cellular toxicity caused by dipeptide repeat proteins (DRPs).
    Type: Application
    Filed: January 26, 2022
    Publication date: May 12, 2022
    Inventors: Fernando G. VIEIRA, Alan PREMASIRI, Anna GILL
  • Patent number: 11210964
    Abstract: A learning tool and method are disclosed. The method which, when executed by a computing device comprising a display, an image capturing device, and a processor, causes the computing device to perform the steps of: generating an interactive first visual cue; displaying the visual cue in a visual cue area on the display; capturing real time footage of a user using the image capturing device while the user interacts with the computing device, and display the real time footage of the user in a video footage area on the display; generating interactive visual content associated with the first visual cue; and displaying the interactive visual content in a visual display area of the display.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: December 28, 2021
    Assignee: KINEPHONICS IP PTY LIMITED
    Inventor: Anna Gill
  • Publication number: 20200405689
    Abstract: Methods are disclosed for treating neurodegenerative disorders, such as ALS and FTD by using an effective amount of a type I protein arginine methyltransferase (Type I PRMT) inhibitor to decrease cellular toxicity caused by dipeptide repeat proteins (DRPs).
    Type: Application
    Filed: June 8, 2020
    Publication date: December 31, 2020
    Inventors: Fernando G. VIEIRA, Alan PREMASIRI, Anna GILL
  • Publication number: 20190347948
    Abstract: A learning tool and method are disclosed. The method which, when executed by a computing device comprising a display, an image capturing device, and a processor, causes the computing device to perform the steps of: generating an interactive first visual cue; displaying the visual cue in a visual cue area on the display; capturing real time footage of a user using the image capturing device while the user interacts with the computing device, and display the real time footage of the user in a video footage area on the display; generating interactive visual content associated with the first visual cue; and displaying the interactive visual content in a visual display area of the display.
    Type: Application
    Filed: December 6, 2017
    Publication date: November 14, 2019
    Inventor: Anna Gill